荣昌生物:3季度末现金储备11.2亿,如何撑到公司盈利?

公司研究室
29 Nov 2024

全文2324字,阅读约需7分钟,帮我划重点划重点01荣昌生物在2024年10月30日至11月6日的投资者关系活动记录表中公布了2024年Q3财务概况和核心管线开发进展。02然而,荣昌生物在不到5年的时间里累计亏损43.65亿元,令投资者担忧公司未来的盈利前景。032024年三季度末,荣昌生物现金及现金等价物余额为6.62亿元,公司在回复沟通函时表示,11.2亿元的现金储备可以维持到公司实现盈利。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10